Koos de Wit

634 total citations
15 papers, 259 citations indexed

About

Koos de Wit is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Koos de Wit has authored 15 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Koos de Wit's work include Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Ethics in Clinical Research (2 papers). Koos de Wit is often cited by papers focused on Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Ethics in Clinical Research (2 papers). Koos de Wit collaborates with scholars based in Netherlands, Belgium and United States. Koos de Wit's co-authors include Barbara A.J. Bastiaansen, Paul Fockens, Manon van der Vlugt, Evelien Dekker, Joep IJspeert, Ulrich Beuers, François Durand, Rajeshwar P. Mookerjee, Elisa Pose and Vı́ctor Vargas and has published in prestigious journals such as Hepatology, Journal of Hepatology and Journal of Medical Internet Research.

In The Last Decade

Koos de Wit

13 papers receiving 255 citations

Peers

Countries citing papers authored by Koos de Wit

Since Specialization

Citations

This map shows the geographic impact of Koos de Wit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koos de Wit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koos de Wit more than expected).

Fields of papers citing papers by Koos de Wit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koos de Wit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koos de Wit. The network helps show where Koos de Wit may publish in the future.

Co-authorship network of co-authors of Koos de Wit

This figure shows the co-authorship network connecting the top 25 collaborators of Koos de Wit. A scholar is included among the top collaborators of Koos de Wit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koos de Wit. Koos de Wit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis 2024 ·Annals of Hepatology ·Koos de Wit, (unknown), Bregje Mol, Lonneke A. van Vught, Frederik Nevens, Ulrich Beuers, Cyriel Y. Ponsioen, Charlotte E. Teunissen, R. Bart Takkenberg	2
2	Increase in prevalence and costs of cirrhosis in the Netherlands: a nationwide hospital diagnosis data analysis 2024 ·European Journal of Gastroenterology & Hepatology ·Koos de Wit, (unknown), Gwen Masclee, Minneke J. Coenraad, (unknown), Frans J.C. Cuperus, Matthijs Kramer, Raoel Maan, (unknown), Marten A. Lantinga, (unknown)	0
3	Opt-In and Opt-Out Consent Procedures for the Reuse of Routinely Recorded Health Data in Scientific Research and Their Consequences for Consent Rate and Consent Bias: Systematic Review 2023 ·Journal of Medical Internet Research ·(unknown), (unknown), Bart Torensma, Koos de Wit, Anneke L. Francke, Mariska Oosterveld‐Vlug, Robert Verheij	26
4	Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality 2023 ·Scandinavian Journal of Gastroenterology ·Koos de Wit, (unknown), (unknown), Lubbertus C. Baak, Ulrich Beuers, R. Bart Takkenberg	2
5	Rifaximin stimulates nitrogen detoxification by PXR‐independent mechanisms in human small intestinal organoids 2022 ·Liver International ·Koos de Wit, Ulrich Beuers, (unknown), Edwin C.A. Stigter, (unknown), José M. Ramos Pittol, Sabine Middendorp, R. Bart Takkenberg, Saskia W. C. van Mil	6
6	Opt-in and opt-out consent procedures for the reuse of routinely recorded health data in scientific research and their consequences for consent rate and consent bias– A systematic review 2022 ·Research Square ·(unknown), (unknown), Bart Torensma, Koos de Wit, (unknown), Anneke L. Francke, Mariska Oosterveld‐Vlug, (unknown)	0
7	The Use of Rifaximin in Patients With Cirrhosis 2021 ·Hepatology ·Paolo Caraceni, Vı́ctor Vargas, Elsa Solà, Carlo Alessandria, Koos de Wit, Jonel Trebicka, Paolo Angeli, Rajeshwar P. Mookerjee, François Durand, Elisa Pose, Aleksander Krag, Jasmohan S. Bajaj, Ulrich Beuers, Pere Ginès	84
8	Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial) 2020 ·BMJ Open Gastroenterology ·Koos de Wit, Jelte J. Schaapman, Frederik Nevens, Jef Verbeek, Samuel Coenen, Frans J.C. Cuperus, (unknown), Eric T.T.L. Tjwa, Nahid Mostafavi, M.G.W. Dijkgraaf, Otto M. van Delden, Ulrich Beuers, Minneke J. Coenraad, R. Bart Takkenberg	31
9	Doppler follow-up after TIPS placement is not routinely indicated. A 16-years single centre experience. 2020 ·PubMed ·Koos de Wit, Otto M. van Delden, Ulrich Beuers, R. Bart Takkenberg	2
10	[A day in the life of a medical resident on the ward]. 2018 ·PubMed ·Alex R. Schuurman, Sarah Bos, Koos de Wit, R. de Graaf, W. Joost Wiersinga	2
11	Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study 2018 ·Alimentary Pharmacology & Therapeutics ·(unknown), Koos de Wit, Adriaan Moelker, (unknown), Otto M. van Delden, Geert Maleux, Nicole S. Erler, R. Bart Takkenberg, Robert A. de Man, Frederik Nevens, Henk R. van Buuren	26
12	Een dag uit het leven van de zaalarts interne geneeskunde 2018 ·Data Archiving and Networked Services (DANS) ·Alex R. Schuurman, Sarah Bos, Koos de Wit, R. de Graaf, W. Joost Wiersinga	2
13	Transjugular intrahepatic portosystemic shunt is highly effective in patients with a MELD score <20 and does not require routine Doppler ultrasound follow-up 2018 ·Journal of Hepatology ·Koos de Wit, Otto van Delden, Ulrich Beuers, (unknown)	1
14	Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists 2016 ·Endoscopy ·Joep IJspeert, Koos de Wit, Manon van der Vlugt, Barbara A.J. Bastiaansen, Paul Fockens, Evelien Dekker	74
15	412 POSTER An open-label study to characterize the pharmacokinetic (pk) parameters of erlotinib in patients with advanced solid tumors with adequate or moderately imparied hepatic function 2006 ·European Journal of Cancer Supplements ·Cindy L. O’Bryant, (unknown), S. Hariharan, Siew Hong Leong, Chandra P. Belani, Rajeev Ramanathan, Ramesh Boinpally, A R Gibbs, Koos de Wit, Sundar Ramalingam	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact